MFN Drug Agreements Could Raise Prices Worldwide

Most Favored Nation (MFN) pricing could meaningfully cut federal drug spending, but much of those savings may evaporate as manufacturers respond by raising prices abroad or delaying launches in lower-priced markets...


Comment
Show comments Hide Comments


Related Articles